BioNTech Authorizes $1.0B Share Repurchase Program

BioNTech SE announced a new share repurchase program, authorizing the company to buy back up to $1.0 billion in American Depositary Shares (ADSs) until May 6, 2027. This program aims to enhance capital efficiency, support long-term value creation, and maintain financial flexibility, aligning with BioNTech's goal to become a multi-product company by 2030. The repurchases will be funded by existing cash resources and are expected to satisfy ordinary course of business obligations. CFO Ramón Zapata stated confidence in long-term growth and commitment to sustainable shareholder value.